These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3061576)

  • 1. Critical care issues in bone marrow transplantation.
    Brochstein JA
    Crit Care Clin; 1988 Jan; 4(1):147-66. PubMed ID: 3061576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
    Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors associated with interstitial pneumonia following allogeneic bone marrow transplantation for acute leukemia in Japanese experience.
    Inoue T; Masaoka T; Shibata H
    Strahlenther Onkol; 1986 Jun; 162(6):368-73. PubMed ID: 3526600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic bone marrow transplantation in the treatment of hematologic diseases.
    Yee GC; McGuire TR
    Clin Pharm; 1985; 4(2):149-60. PubMed ID: 3886273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic marrow transplantation for patients with acute leukemia.
    Buckner CD
    Transplant Proc; 1979 Mar; 11(1):215-8. PubMed ID: 377636
    [No Abstract]   [Full Text] [Related]  

  • 6. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
    Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
    Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
    Long GD; Amylon MD; Stockerl-Goldstein KE; Negrin RS; Chao NJ; Hu WW; Nademanee AP; Snyder DS; Hoppe RT; Vora N; Wong R; Niland J; Reichardt VL; Forman SJ; Blume KG
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):324-30. PubMed ID: 9502300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful allogeneic bone marrow transplantation for three children with acute nonlymphocytic leukemia.
    Ohira M; Takayama J; Hanada M
    Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():487-93. PubMed ID: 6097709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia.
    Jillella AP; Doria R; Khan K; Zelterman D; Ahmad YH; Smith BR; Holmes W; Becker P; Roberts KB; Rappeport JM
    Bone Marrow Transplant; 1999 Jun; 23(11):1095-100. PubMed ID: 10382947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic bone marrow transplant in acute leukemias and chronic myeloid leukemia. Preliminary results from the BMT center of Pesaro.
    Izzi T; Polchi P; Galimberti M; Delfini C; Moretti L; Manna A; Porcellini A; Lucarelli G; Di Pietrantonj F
    Haematologica; 1984; 69(2):194-210. PubMed ID: 6429005
    [No Abstract]   [Full Text] [Related]  

  • 11. Allogeneic BMT for acute leukemia [proceedings].
    Cornu P; Speck B; Groff P; Nissen C; Sartorius J; Burri HP; Ohnacker H
    Pathol Biol (Paris); 1978 Jan; 26(1):49-50. PubMed ID: 358089
    [No Abstract]   [Full Text] [Related]  

  • 12. Lethal complications in 30 patients after allogeneic BMT (BMT) and autografted (ABMT) patients (1980-1986) examined by autopsy.
    Friedrich T; Püschel W; Helbig W; Kubel M; Hoffmann FA; Schwenke H; Pönisch W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):585-9. PubMed ID: 2480313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
    Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine.
    Mehta J; Powles R; Treleaven J; Horton C; Tait D; Meller S; Pinkerton CR; Middleton G; Eisen T; Singhal S
    Bone Marrow Transplant; 1996 Oct; 18(4):741-6. PubMed ID: 8899189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful renal transplantation following prior bone marrow transplantation in pediatric patients.
    Thomas SE; Hutchinson RJ; DebRoy M; Magee JC
    Pediatr Transplant; 2004 Oct; 8(5):507-12. PubMed ID: 15367289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide.
    Duerst RE; Horan JT; Liesveld JL; Abboud CN; Zwetsch LM; Senf ES; Constine LS; Raubertas RF; Passarell JA; DiPersio JF
    Bone Marrow Transplant; 2000 Mar; 25(5):489-94. PubMed ID: 10713624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
    Wu DP; Milpied N; Moreau P; Mechinaud-Lacroix F; Mahe B; Le Tortorec S; Rapp MJ; Bourdin S; Mahe JM; Harousseau JL
    Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
    Michel G; Leverger G; Leblanc T; Nelken B; Baruchel A; Landman-Parker J; Thuret I; Bergeron C; Bordigoni P; Esperou-Bourdeau H; Perel Y; Vannier JP; Schaison G
    Bone Marrow Transplant; 1996 Feb; 17(2):191-6. PubMed ID: 8640165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of second bone marrow transplantation following a uniform conditioning regimen as therapy for malignant relapse.
    Chiang KY; Weisdorf DJ; Davies SM; Enright H; Kersey JH; McGlave PB; Miller W; Ramsay NK; Steinbuch M; Wagner JE; Blazar BR
    Bone Marrow Transplant; 1996 Jan; 17(1):39-42. PubMed ID: 8673052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sixteen adult patients with acute leukemia treated by chemotherapy, total body irradiation and allogeneic marrow transplantation.
    Kodera Y; Morishima Y; Morishita Y; Murase T; Okumura M; Yamada H; Minami S; Kato Y; Ogura M; Nagura E
    Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():479-85. PubMed ID: 6394811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.